Document Detail


Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project.
MedLine Citation:
PMID:  10423077     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In 1998 the final results were presented of two large intervention trials in hypertension, the Hypertension Optimal Treatment Study (HOT) and the Captopril Prevention Project (CAPPP). Both were initiated from Sweden although the HOT Study was conducted in 26 countries worldwide and the CAPPP Study in Finland and Sweden. The HOT and CAPPP trials and their principal results will be reviewed briefly here. In addition a brief up-date will be provided of three ongoing intervention trials in hypertension that were also initiated from Sweden: the Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-), the Nordic Diltiazem (NORDIL) Study and the Study on Cognition and Prognosis in Elderly Hypertensives (SCOPE).
Authors:
L Hansson
Related Documents :
7783257 - Role of the pericytes of intra-acinar pulmonary artery in the structural remodeling of ...
3717697 - Development of pulmonary aneurysm in primary pulmonary hypertension: a case report.
11451277 - Pulmonary artery reflection for differentially diagnosing primary pulmonary hypertensio...
17185187 - Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hyp...
6332597 - New computed tomographic signs of aortoenteric fistula.
15127857 - What have we learned from the imaging in carotid angioplasty and risk of stroke (icaros...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  21     ISSN:  1064-1963     ISO Abbreviation:  Clin. Exp. Hypertens.     Publication Date:    1999 Jul-Aug
Date Detail:
Created Date:  1999-12-01     Completed Date:  1999-12-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  507-15     Citation Subset:  IM    
Affiliation:
Department of PublicHealth and Social Sciences: Geriatrics, University of Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Adult
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Aspirin / therapeutic use
Blood Pressure*
Calcium Channel Blockers / therapeutic use
Captopril / therapeutic use
Cardiovascular Diseases / mortality,  prevention & control*
Clinical Trials as Topic
Felodipine / therapeutic use
Female
Humans
Hypertension / drug therapy*
Isradipine / therapeutic use
Male
Middle Aged
Randomized Controlled Trials as Topic
Stroke / prevention & control
Sweden
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Calcium Channel Blockers; 50-78-2/Aspirin; 62571-86-2/Captopril; 72509-76-3/Felodipine; 75695-93-1/Isradipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Implications of the Systolic Hypertension in China trial.
Next Document:  An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. Wor...